| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |